Table 4.
Comparison of clinical outcomes of the subsequent FET cycles between the morphology assessment plus aCGH screening (Group A) and the morphology assessment alone (Group B)
| Parameters | Group A | Group B | p value |
|---|---|---|---|
|
Patients completed FET cycles |
15 |
23 |
|
|
Patients with SET |
10 (66.7%) |
4 (17.4%) |
|
|
Patients with DET |
5 (33.3%) |
19 (82.6%) |
0.006a |
|
Clinical pregnancy |
10 (66.7%) |
12 (52.2%) |
0.583a |
|
Ongoing pregnancy (≥20 weeks GA) |
10 (66.7%) |
10 (43.5%) |
0.286a |
|
Implantation |
13 (65.0%) |
14 (33.3%) |
0.038a |
|
Twin pregnancy |
3 (30.0%) |
2 (16.7%) |
0.624b |
| Miscarriage | 0 | 2 (16.7%) | 0.481b |
SET = single embryo transfer, DET = double embryo transer, GA = gestational age; aby Chi-square analysis; bby Fisher’s exact test.